Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
Dr. Steven Henikoff, a molecular biologist at Fred Hutch Cancer Center, has won the prestigious Rosenstiel Award for ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
Sorghum bicolor is a deep-rooted, heat- and drought-tolerant crop that thrives on marginal lands and is increasingly valued ...
Georgia Burton is making the most of her opportunities at the University of Maine at Fort Kent as she pursues her ultimate ...
A team of Northwestern investigators has discovered novel molecular underpinnings of a common oncogenic mutation in cancer, ...
A research team at the Max Planck Institute for Chemical Ecology has successfully combined single-cell RNA sequencing (scRNA-seq) and single-cell mass spectrometry (scMS) analysis on the same plant ...
An international research team led by Hiroki Shibuya at RIKEN Center for Biosystems Dynamics Research (BDR) in Japan has ...
MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...
In the U.S. alone, more than 6.7 million people have heart failure, a number that is projected to increase to more than 8.5 ...
Humans have become very good at altering the basic building blocks of life to their advantage. Genetically modified foods are available at most grocery stores. Researchers use gene-editing tools every ...